Patent · US Active

Eukaryotic translation initiation factors (EIFS) as novel biomarkers in head and neck squamous cell carcinoma (HNSCC)

US11493517B2 · kind B2 · utility

0Cited by

0References

7Claims

0Family size

Assignee

OTTO-VON-GUERICKE-UNIVERSITAT MAGDEBURG · DE

Inventors

Johannes Haybäck · Innsbruck, AT
Anna Maria Cyran · Magdeburg, DE
Christoph Arens · Magdeburg, DE
Michael Naumann · Feucht, DE

Key dates

Filing date	Apr 6, 2020
Grant date	Nov 8, 2022
Priority date	—
Expiry date	Jul 23, 2040

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/91215
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention relates to a method of diagnosing Head and Neck Squamous Cell Carcinoma (HNSCC) in an individual. In addition, the present invention relates to a method of providing a survival prognosis to an individual suffering from Head and Neck Squamous Cell Carcinoma (HNSCC). Moreover, the present invention relates to a kit for performing the above-mentioned methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.